- Report
- April 2021
- 50 Pages
China
From €2365EUR$2,600USD£2,021GBP
- Report
- December 2020
- 63 Pages
Germany
From €545EUR$620USD£450GBP
- Report
- December 2020
- 200 Pages
Global
€4048EUR$4,450USD£3,460GBP
- Report
- August 2019
- 30 Pages
China
From €2001EUR$2,200USD£1,710GBP
- Report
- July 2019
- 26 Pages
China
- Book
- April 2019
- 836 Pages
Canada
- Report
- July 2026
Global
From €3629EUR$3,990USD£3,102GBP
From €3629EUR$3,990USD£3,102GBP
- Report
- July 2026
United States
From €3629EUR$3,990USD£3,102GBP
- Report
- July 2026
United Kingdom
From €3629EUR$3,990USD£3,102GBP
- Report
- July 2026
North America
From €3629EUR$3,990USD£3,102GBP
- Report
- July 2026
Europe
From €3629EUR$3,990USD£3,102GBP
- Report
- July 2026
Middle East
From €3629EUR$3,990USD£3,102GBP
- Report
- July 2026
Asia Pacific
From €3629EUR$3,990USD£3,102GBP
- Report
- July 2026
Europe
From €3629EUR$3,990USD£3,102GBP
- Report
- August 2025
- 41 Pages
From €455EUR$500USD£389GBP
- Report
- July 2026
- 160 Pages
Global
From €3020EUR$3,320USD£2,581GBP
€3775EUR$4,150USD£3,226GBP
- Report
- September 2025
- 87 Pages
Global
From €3500EUR$4,122USD£3,096GBP
- Report
- February 2026
- 123 Pages
Global
From €3500EUR$4,122USD£3,096GBP
- Report
- November 2025
- 100 Pages
Global
From €3500EUR$4,122USD£3,096GBP

The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more